376 related articles for article (PubMed ID: 23821540)
21. Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome.
Liebergall SR; Goldberg EM
J Neurosci; 2024 Apr; 44(17):. PubMed ID: 38443186
[TBL] [Abstract][Full Text] [Related]
22. Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome.
Maeda H; Chiyonobu T; Yoshida M; Yamashita S; Zuiki M; Kidowaki S; Isoda K; Yamakawa K; Morimoto M; Nakahata T; Saito MK; Hosoi H
J Hum Genet; 2016 Jun; 61(6):565-9. PubMed ID: 26841829
[TBL] [Abstract][Full Text] [Related]
23. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK
J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083
[TBL] [Abstract][Full Text] [Related]
24. Case studies in neuroscience: a novel amino acid duplication in the NH
Angus M; Peters CH; Poburko D; Brimble E; Spelbrink EM; Ruben PC
J Neurophysiol; 2019 Nov; 122(5):1975-1980. PubMed ID: 31533007
[TBL] [Abstract][Full Text] [Related]
25. Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine.
Lemaire L; Desroches M; Krupa M; Pizzamiglio L; Scalmani P; Mantegazza M
PLoS Comput Biol; 2021 Jul; 17(7):e1009239. PubMed ID: 34314446
[TBL] [Abstract][Full Text] [Related]
26. Epilepsy channelopathies go neddy: stabilizing NaV1.1 channels by neddylation.
Cannon SC
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33855971
[TBL] [Abstract][Full Text] [Related]
27. CRISPR/Cas9 facilitates investigation of neural circuit disease using human iPSCs: mechanism of epilepsy caused by an SCN1A loss-of-function mutation.
Liu J; Gao C; Chen W; Ma W; Li X; Shi Y; Zhang H; Zhang L; Long Y; Xu H; Guo X; Deng S; Yan X; Yu D; Pan G; Chen Y; Lai L; Liao W; Li Z
Transl Psychiatry; 2016 Jan; 6(1):e703. PubMed ID: 26731440
[TBL] [Abstract][Full Text] [Related]
28. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
[TBL] [Abstract][Full Text] [Related]
29. Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome.
Kurbatova P; Wendling F; Kaminska A; Rosati A; Nabbout R; Guerrini R; Dulac O; Pons G; Cornu C; Nony P; ; Chiron C; Benquet P
Exp Neurol; 2016 Sep; 283(Pt A):57-72. PubMed ID: 27246997
[TBL] [Abstract][Full Text] [Related]
30. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome.
Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK
Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701
[TBL] [Abstract][Full Text] [Related]
31. Developmental alterations in firing properties of hippocampal CA1 inhibitory and excitatory neurons in a mouse model of Dravet syndrome.
Almog Y; Fadila S; Brusel M; Mavashov A; Anderson K; Rubinstein M
Neurobiol Dis; 2021 Jan; 148():105209. PubMed ID: 33271326
[TBL] [Abstract][Full Text] [Related]
32. A human Dravet syndrome model from patient induced pluripotent stem cells.
Higurashi N; Uchida T; Lossin C; Misumi Y; Okada Y; Akamatsu W; Imaizumi Y; Zhang B; Nabeshima K; Mori MX; Katsurabayashi S; Shirasaka Y; Okano H; Hirose S
Mol Brain; 2013 May; 6():19. PubMed ID: 23639079
[TBL] [Abstract][Full Text] [Related]
33. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
Lopez-Santiago L; Isom LL
Epilepsy Curr; 2019 Jan; 19(1):51-53. PubMed ID: 30838929
[TBL] [Abstract][Full Text] [Related]
34. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene.
Tanaka Y; Sone T; Higurashi N; Sakuma T; Suzuki S; Ishikawa M; Yamamoto T; Mitsui J; Tsuji H; Okano H; Hirose S
Stem Cell Res; 2018 Apr; 28():100-104. PubMed ID: 29453127
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene.
Tanaka Y; Higurashi N; Shirasu N; Yasunaga S; Moreira KM; Okano H; Hirose S
Stem Cell Res; 2018 Aug; 31():11-15. PubMed ID: 29981888
[TBL] [Abstract][Full Text] [Related]
36. The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model.
Zayat V; Kuczynska Z; Liput M; Metin E; Rzonca-Niewczas S; Smyk M; Mazurczak T; Goszczanska-Ciuchta A; Leszczynski P; Hoffman-Zacharska D; Buzanska L
Cells; 2023 Jan; 12(2):. PubMed ID: 36672274
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.
Zhang Y; Kecskés A; Copmans D; Langlois M; Crawford AD; Ceulemans B; Lagae L; de Witte PA; Esguerra CV
PLoS One; 2015; 10(5):e0125898. PubMed ID: 25965391
[TBL] [Abstract][Full Text] [Related]
38. Synaptic Integration in CA1 Pyramidal Neurons Is Intact despite Deficits in GABAergic Transmission in the
Chancey JH; Howard MA
eNeuro; 2022; 9(3):. PubMed ID: 35523580
[TBL] [Abstract][Full Text] [Related]
39. Generation of a human iPSC line (UUIGPi015-A) from a patient with Dravet syndrome and a 2.9 Mb deletion spanning SCN1A on chromosome 2.
Schuster J; de Guidi C; Tripathi R; Klar J; Dahl N
Stem Cell Res; 2022 Apr; 60():102712. PubMed ID: 35203050
[TBL] [Abstract][Full Text] [Related]
40. Dissecting the phenotypes of Dravet syndrome by gene deletion.
Rubinstein M; Han S; Tai C; Westenbroek RE; Hunker A; Scheuer T; Catterall WA
Brain; 2015 Aug; 138(Pt 8):2219-33. PubMed ID: 26017580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
